Related Experiment Video

Updated: May 7, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Following up tumor-specific regulatory T cells in cancer patients

Laurence Zitvogel1, Corinne Tanchot, Clemence Granier

  • 1INSERM, U1015; Villejuif, France ; Institut Gustave Roussy; Villejuif, France ; CICBT507; Villejuif, France ; Université Paris Sud; Le Kremlin Bicêtre, France.

Oncoimmunology
|September 28, 2013
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cancer vaccineimmunomonitoringimmunosuppressionregulatory T celltumor antigen

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.